FINN SEGMENTAL FEMORAL 153804

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 06 report with the FDA on 2002-04-30 for FINN SEGMENTAL FEMORAL 153804 manufactured by Biomet, Inc..

Event Text Entries

[246305] Revision left total arthroplasty performed in 1999. Due to pain and instability, revision performed in 2002. Surgeon noted rotation of femoral component intraoperatively.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1825034-2002-00044
MDR Report Key391035
Report Source06
Date Received2002-04-30
Date of Report2002-04-29
Date of Event2002-02-27
Date Mfgr Received2002-03-29
Device Manufacturer Date1999-07-01
Date Added to Maude2002-05-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactBETH ALBERT, AST
Manufacturer StreetPO BOX 587
Manufacturer CityWARSAW IN 465810587
Manufacturer CountryUS
Manufacturer Postal465810587
Manufacturer Phone5742676639
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameFINN SEGMENTAL FEMORAL
Generic NamePROSTHESIS, KNEE, COMP
Product CodeKRQ
Date Received2002-04-30
Model NumberNA
Catalog Number153804
Lot Number026010
ID NumberNA
Device Expiration Date2009-07-01
Device Eval'ed by MfgrR
Implant FlagY
Date Removed*
Device Sequence No1
Device Event Key380081
ManufacturerBIOMET, INC.
Manufacturer AddressP.O. BOX 587 WARSAW IN 465810587 US
Baseline Brand NameFINN SEGMENTAL FEMORAL
Baseline Generic NamePROSTHESIS, KNEE, COMP
Baseline Model NoNA
Baseline Catalog No153804
Baseline IDNA
Baseline Device FamilyFINN SEGMENTAL FEMORAL
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]120
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK974558
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2002-04-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.